SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-011385
Filing Date
2022-02-03
Accepted
2022-02-03 16:30:35
Documents
2
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm225348d5_3.html 3  
1 OWNERSHIP DOCUMENT tm225348d5_3.xml 3 1621
2 EXHIBIT 24.1 tm225348d5_ex24-1.htm EX-24.1 9611
  Complete submission text file 0001104659-22-011385.txt   12703
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 97 WILLISTON RD BROOKLINE MA 02445
Business Address
Parsons Erin (Reporting) CIK: 0001895795 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 22588860